Virological breakthrough is not a detrimental phenomenon in patients with compensated cirrhosis:: Results of a long term lamivudine therapy

---

Cakaloglu Y., Kaymakoglu S., Akyuz F., Ibrisim D., Demir K., Onel D., ...More

56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 11 - 15 November 2005, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: San-Francisco
• Country: Costa Rica
• Istanbul University Affiliated: Yes